ClinicalTrials.gg
RecruitingNCT06472245ARTEMIAUpdated Nov 12, 2026

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

A Phase 3 interventional study of OSE2101 and Docetaxel in Patients With Non-Small Cell Lung Cancer, sponsored by OSE Immunotherapeutics. Recruiting at 207 sites in 14 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by OSE Immunotherapeutics · Phase 3, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.
Updated Nov 12, 2026Site recruiting status changedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
363
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 3,374 studies in Carcinoma, Non-Small-Cell Lung with a site in United States — 521 open to participants now, 895 under way, 141 of them phase 3. Carcinoma, Non-Small-Cell Lung · United States.

Planned enrollment
380th of 3,001
363 · median 56
Started
2024
with 157 others
Phase 3
353 of 3,374
52 open now
Primary completion
2028-05
later than 597 of 893 live
Registered
3,033rd of 3,374
by date

Among the 3,374 studies in Carcinoma, Non-Small-Cell Lung with a site in United States, this one is the 380th largest by planned enrollment of the 3,001 interventional ones that give a count, is one of 158 that started in 2024, is one of 353 in phase 3, reaches primary completion later than 597 of the 893 other live ones, and was the 3,033rd registered.

Carcinoma, Non-Small-Cell Lung

7,639 studies on the registry are indexed under Carcinoma, Non-Small-Cell Lung; 1,838 are open to participants now.

Browse Carcinoma, Non-Small-Cell Lung studies →

Open to participants now

521 of the 3,374 studies in Carcinoma, Non-Small-Cell Lung with a site in United States are open now. Recruiting first, the newest first:

516 more — sign in →

All 521 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 1,324 Carcinoma, Non-Small-Cell Lung studies recruiting now, 987 (75%) set no upper age limit and 225 (17%) stop at 75 or younger; 34 take children under 18; 40 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 3,374 studies in Carcinoma, Non-Small-Cell Lung with a site in United States, or all of them as a file.
02

Study summary

Multicenter, randomized (2:1), open-label phase 3 study in HLA-A2 positive patients with squamous and non-squamous metastatic NSCLC with ICI secondary resistance.

Patients will be randomized into 2 arms (randomization 2:1): experimental Arm A with OSE2101 monotherapy or control Arm B SoC with docetaxel monotherapy. Stratification factors will be histology (squamous versus non squamous) and ECOG Performance Status (0 versus 1).

03

Conditions studied

  • Patients With Non-Small Cell Lung Cancer

Keywords

  • Immune Checkpoint Inhibitor
  • Cancer vaccine
  • Non-Small Cell Lung Cancer
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  1. Male or female, aged ≥ 18 years
  2. Patients expressing HLA-A2 phenotype in blood by pre-screening central laboratory
  3. Patients with histologically or cytologically squamous or non-squamous documented NSCLC, stage at study entry, not eligible for definite surgery or radiation, without EGFR, ALK and ROS1 gene alterations eligible for targeted therapy; for patients with squamous NSCLC, the molecular tests are not mandatory if age ≥ 50 years old and smoker ≥ 15 pack years; other sensitizing mutations known to be immunosensitive are eligible in case of lack of local access to targeted therapy (i.e.; KRAS G12C and BRAF mutations) after Sponsor' agreement.
  4. Patients with secondary resistance to ICI;

Other inclusion and exclusion criteria will apply per protocol.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
363 participants (estimated)

Study arms

  • Experimental
    Arm A: OSE2101

    Unit dose: 1 mL corresponding to a total of 5 mg of the combination of peptides Mode/Route: Subcutaneous injection Regimen: One injection every three weeks for six cycles, then every eight weeks for the remainder of year one and, finally every twelve weeks until the end of second year.

    Drug: OSE2101 · Device: NGS HLAA2 assay

  • Active comparator
    Arm B: Docetaxel

    Unit dose: 75 mg/m2 Mode/Route: Intravenous infusion over 1 hour Regimen: One infusion every three weeks.

    Drug: Docetaxel · Device: NGS HLAA2 assay

  • Other
    GenDx CDx Tedopi

    System of qualitative companion diagnostic devices, consisting of a polymerase chain reaction (PCR) assay Amp-HLA-A-CDx Tedopi, a DNA library preparation assay, LFK-CDx Tedopi and the software NGSengine-CDx Tedopi.

    Device: NGS HLAA2 assay

Interventions

  • DrugMulti-neo-epitope Vaccine OSE 2101Studies of Multi-neo-epitope Vaccine OSE 2101Multi-neo-epitope Vaccine OSE 2101 pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    OSE2101 is a peptidic cancer vaccine composed of nine epitopes restricted to HLA-A2 phenotype targeting the tumor associated antigens of P53, HER-2, CEA, MAGE-2 and MAGE-3, and one pan-HLA DR binding epitope (PADRE), all epitopes emulsified in Montanide ISA 51TM adjuvant.

  • Docetaxel is an antineoplastic agent that acts by disrupting the microtubular network in cells that is essential for mitotic and interphase cellular functions.

  • DeviceNGS HLAA2 assay

    Amp-HLA-A-CDx Tedopi for amplification of human genomic DNA (gDNA), LFK-CDx Tedopi kit (library full kit) for library preparation, NGSengine-CDx Tedopi software for analysis of NGS data files.

06

What researchers measure

Primary outcomes

  1. OS defined as time from randomization to death

    OS defined as time from randomization to death of any cause, censored until the data analysis cut-off date

    Time frame: From randomization date through study completion, an average of 3 years

07

Study locations

154 of 207 sites recruiting
  • Clinical Research Advisors, LLC
    Beverly Hills, California 90211, United States
    Recruiting
  • Clinical Research Advisors - Encino
    Encino, California 90211, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Clinical Research Advisors - West Hollywood
    Los Angeles, California 90048, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Clinical Research Advisors - Korea Town
    Los Angeles, California 90211, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • SCL Health - Saint Joseph Hospital Cancer Center
    Littleton, Colorado 80218, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Lutheran Medical Center - Cancer Centers of Colorado
    Wheat Ridge, Colorado 80033-6013, United States
    Recruiting
  • Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360, United States
    Recruiting
  • Georgetown Lombardi Comprehensive Cancer Center
    Washington D.C., District of Columbia 20007, United States
    Recruiting
  • Comprehensive Hematology Oncology - Bradenton Clinic
    Bradenton, Florida 34210, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Comprehensive Hematology Oncology - Brandon Clinic
    Brandon, Florida 33511, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cancer Specialists of North Florida - Fleming Island
    Fleming Island, Florida 32003, United States
    Recruiting
  • Cancer Specialists of North Florida - Riverside
    Jacksonville, Florida 32204, United States
    Recruiting
  • Cancer Specialists of North Florida Southside
    Jacksonville, Florida 32207, United States
    Recruiting
  • Cancer Specialists of North Florida - Northside
    Jacksonville, Florida 32218, United States
    Recruiting
  • Cancer Specialists of North Florida - Southpoint
    Jacksonville, Florida 32256-6932, United States
    Recruiting
  • Cancer Specialists of North Florida - Baptist South
    Jacksonville, Florida 32258, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cancer Specialists of North Florida
    Jacksonville Beach, Florida 32250, United States
    Recruiting
  • Comprehensive Hematology Oncology - Largo Clinic
    Largo, Florida 33770, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cancer Specialists of North Florida - Beaches
    Neptune Beach, Florida 32266, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Comprehensive Hematology Oncology - Palm Harbor Clinic
    Palm Harbor, Florida 34685, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cancer Specialists Of North Florida - St. Augustine
    Saint Augustine, Florida 32086, United States
    Recruiting
  • Comprehensive Hematology Oncology - Bayfront Clinic
    St. Petersburg, Florida 33709, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Comprehensive Hematology Oncology
    St. Petersburg, Florida 33709, United States
    Recruiting
  • Comprehensive Hematology Oncology - Trinity Clinic
    Trinity, Florida 34655, United States
    Recruiting
  • University of Illinois Cancer Center
    Chicago, Illinois 60612, United States
    Recruiting
  • Alliance for Multispecialty Research (AMR) - Kansas City Oncology
    Merriam, Kansas 66204, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Mary Bird Perkins Cancer Center - Baton Rouge
    Baton Rouge, Louisiana 70809, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Pontchartrain Cancer Center - Covington Office
    Covington, Louisiana 70433, United States
    Recruiting
  • Pontchartrain Cancer Center - Hammond Office
    Hammond, Louisiana 70403-1452, United States
    Recruiting
  • Ascension Saint Agnes Hospital
    Baltimore, Maryland 21229, United States
    Recruiting
  • University of Massachusetts Memorial Medical Center
    Worcester, Massachusetts 01655, United States
    Recruiting
  • Nebraska Hematology-Oncology - Revive Research Institute LLC
    Lincoln, Nebraska 68506, United States
    Recruiting
  • New York Cancer & Blood Specialists - Babylon Medical Oncology
    Babylon, New York 11702, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Optum Medical Care - Carmel/Brewster Campus
    Brewster, New York 10509, United States
    Terminated

    Not enrolling at this site — choose another above.

  • Brooklyn Radiation Oncology
    Brooklyn, New York 11201, United States
    Terminated

    Not enrolling at this site — choose another above.

  • Optum Medical Care - Fishkill Westage Campus
    Fishkill, New York 12524, United States
    Terminated

    Not enrolling at this site — choose another above.

  • Clinical Research Alliance
    Lake Success, New York 11042, United States
    Terminated

    Not enrolling at this site — choose another above.

  • Optum Medical Care - Mount Kisco Campus 90
    Mount Kisco, New York 10549, United States
    Terminated

    Not enrolling at this site — choose another above.

  • New York Cancer & Blood Specialists - New Hyde Park
    New Hyde Park, New York 11042, United States
    Recruiting
  • Optum Hematology Oncology - Lake Success
    New Hyde Park, New York 11042, United States
    Terminated

    Not enrolling at this site — choose another above.

  • New York Cancer & Blood Specialists - Cancer Center - Research Headquarters
    New York, New York 10028, United States
    Recruiting
  • New York Cancer & Blood Specialists - Central Park Medical Oncology
    New York, New York 10028, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • New York Cancer & Blood Specialists - Patchogue Medical Oncology
    Patchogue, New York 11772, United States
    Recruiting
  • New York Cancer & Blood Specialists - Port Jefferson Medical Oncology
    Port Jefferson Station, New York 11776, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • New York Cancer & Blood Specialists - Port Jefferson Station Medical Oncology
    Port Jefferson Station, New York 11776, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Optum Medical Care - Poughkeepsie
    Poughkeepsie, New York 12601, United States
    Terminated

    Not enrolling at this site — choose another above.

  • New York Cancer & Blood Specialists - Eastchester Cancer Care Center
    The Bronx, New York 10469, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • New York Cancer & Blood Specialists - Riverhead Medical Oncology
    The Bronx, New York 10469, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Mercy Health - Perrysburg Cancer Center
    Perrysburg, Ohio 43551, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Mercy Health - St. Anne Cancer Center
    Toledo, Ohio 43623, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Bon Secours Hematology and Oncology
    Greenville, South Carolina 29607, United States
    Recruiting
  • Tennessee Oncology - Chattanooga - Medical Park II
    Chattanooga, Tennessee 36404, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Chattanooga - Downtown
    Chattanooga, Tennessee 37403, United States
    Recruiting
  • Tennessee Oncology - Chattanooga - GHCR Site I
    Chattanooga, Tennessee 37403, United States
    Recruiting
  • Tennessee Oncology - Chattanooga - Memorial Plaza
    Chattanooga, Tennessee 37404, United States
    Recruiting
  • Tennessee Oncology - Cleveland Clinic
    Cleveland, Tennessee 37311, United States
    Recruiting
  • Tennessee Oncology - Cookeville Clinic
    Cookeville, Tennessee 38501, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Dickson Clinic
    Dickson, Tennessee 37055, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Franklin Clinic
    Franklin, Tennessee 37067, United States
    Recruiting
  • Tennessee Oncology - Gallatin Clinic
    Gallatin, Tennessee 37066, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Hendersonville Clinic
    Hendersonville, Tennessee 37075, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Hermitage - Summit Clinic
    Hermitage, Tennessee 37076, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Lebanon Clinic
    Lebanon, Tennessee 37090, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Murfreesboro Clinic
    Murfreesboro, Tennessee 37129, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Nashville - Centennial Center for Blood Cancers Clinic
    Nashville, Tennessee 37203, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Nashville - Centennial Clinic - Medical Oncology
    Nashville, Tennessee 37203, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Nashville - Midtown Center for Blood Cancers
    Nashville, Tennessee 37203, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Nashville - St. Thomas Midtown Clinic
    Nashville, Tennessee 37203, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Nashville - St. Thomas West Clinic
    Nashville, Tennessee 37205, United States
    Recruiting
  • Tennessee Oncology - Nashville - Skyline Clinic
    Nashville, Tennessee 37207, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tennessee Oncology - Nashville - Southern Hills Clinic
    Nashville, Tennessee 37211, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Greco-Hainsworth Tennessee Oncology Centers for Research (GHCR) - Corporate
    Nashville, Tennessee 37232, United States
    Recruiting
  • Tennessee Oncology - Shelbyville Clinic
    Shelbyville, Tennessee 37160, United States
    Recruiting
  • Tennessee Oncology - Smyrna Clinic
    Smyrna, Tennessee 37167, United States
    Recruiting
  • Northwest Medical Specialties - Bonney Lake
    Bonney Lake, Washington 98391, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Northwest Medical Specialties - Federal Way
    Federal Way, Washington 98003, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Northwest Medical Specialties - Gig Harbor
    Gig Harbor, Washington 98332, United States
    Recruiting
  • Northwest Medical Specialties - Puyallup Medical Oncology
    Puyallup, Washington 98373, United States
    Recruiting
  • Northwest Medical Specialties - Tacoma
    Tacoma, Washington 98405, United States
    Recruiting
  • Algemeen Ziekenhuis Klina
    Brasschaat, Antwerpen 2930, Belgium
    Recruiting
  • Universitair Ziekenhuis Leuven - Campus Gasthuisberg
    Leuven, Flemish Brabant 3000, Belgium
    Recruiting
  • Jessa Ziekenhuis - Campus Virga Jesse
    Hasselt, Limburg 3500, Belgium
    Recruiting
  • Algemeen Ziekenhuis Maria Middelares
    Ghent, Oost-Vlaaderen 9000, Belgium
    Recruiting
  • Centre Hospitalier Universitaire Université Catholique de Louvain Namur - Site Sainte-Elisabeth
    Namur, Wallonia B-5000, Belgium
    Recruiting
  • Algemeen Ziekenhuis Groeninge - Campus Kennedylaan
    Kortrijk, West-Vlaanderen 8500, Belgium
    Recruiting
  • Algemeen Ziekenhuis Delta - Campus Rembert Torhout
    Roeselare, West-Vlaanderen 8800, Belgium
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Algemeen Ziekenhuis Delta - Campus Rumbeke
    Roeselare, West-Vlaanderen 8800, Belgium
    Recruiting
  • Algemeen Ziekenhuis Delta - Campus Menen
    Roeselare, West-Vlaanderen, Belgium
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay - Lac-Saint-Jean
    Chicoutimi, Quebec G7H 5H6, Canada
    Recruiting
  • McGill University Health Centre
    Montreal, Quebec H4A 3J1, Canada
    Terminated

    Not enrolling at this site — choose another above.

  • Centre Intégré de Santé et de Services Sociaux du Bas-Saint-Laurent
    Rimouski, Quebec G5L 5T1, Canada
    Recruiting
  • Hôpital d'Instruction des Armées Sainte-Anne
    Toulon, Alpes-de-Haute-Provence 83800, France
    Recruiting
  • Nouvel Hôpital Civil
    Strasbourg, Alsace 67091, France
    Recruiting
  • Hôpital Louis Pradel
    Bron, Auvergne-Rhône-Alpes 69500, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Centre Hospitalier Lyon-Sud
    Lyon, Auvergne-Rhône-Alpes 69317, France
    Recruiting
  • Hôpital de la Croix Rousse
    Lyon, Auvergne-Rhône-Alpes 69317, France
    Recruiting
  • Institut Paoli-Calmettes
    Marseille, Bouches-du-Rhône 13273, France
    Recruiting
  • Centre Hospitalier Régional et Universitaire de Besançon - Hôpital Jean-Minjoz
    Besançon, Doubs 25030, France
    Recruiting
  • Centre Hospitalier Regional Universitaire Brest - Hopital de la Cavale Blanche
    Brest, Finistère 29200, France
    Recruiting
  • Hôpital Emile Muller
    Mulhouse, Grand Est 68100, France
    Recruiting

Showing the first 100 of 207 sites across 14 countries. Choose a country and city above to see the rest.

08

References and documents

Publications

  • Besse B, Felip E, Garcia Campelo R, Cobo M, Mascaux C, Madroszyk A, Cappuzzo F, Hilgers W, Romano G, Denis F, Viteri S, Debieuvre D, Galetta D, Baldini E, Razaq M, Robinet G, Maio M, Delmonte A, Roch B, Masson P, Schuette W, Zer A, Remon J, Costantini D, Vasseur B, Dziadziuszko R, Giaccone G; ATALANTE-1 study group. Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1. Ann Oncol. 2023 Oct;34(10):920-933. doi: 10.1016/j.annonc.2023.07.006. Epub 2023 Sep 11. PubMed 37704166 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for May 2028, 40 months after the start.

Of 314 industry-sponsored phase 3 interventional studies under Carcinoma, Non-Small-Cell Lung, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 57. This study's planned 40 months is close to that.

Counting every sponsor, half of 423 studies reached it within 45 months; a quarter within 30 and three quarters within 69.

Primary completion moved once since we started tracking on Sep 25, 2026: Dec 2027 → May 2028, on Nov 12, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 7, 2024
First posted
Jun 25, 2024
StartActual
Dec 3, 2024
Primary completionEst.
May 1, 2028was Dec 2027
CompletionEst.
Dec 15, 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
31 sites added, 31 sites removed. 3 sites changed recruiting status (2 now recruiting, 1 now terminated)
Show 3 sites
  • Cancer Specialists of North Florida Southside · Jacksonville, United StatesActive, not recruiting→Recruiting
  • Universitätsklinikum Aachen · Aachen, GermanyRecruiting→Terminated
  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Istituto Clinico Humanitas · Rozzano, ItalyActive, not recruiting→Recruiting
Show 31 added (12 Spain, 11 Italy, 5 Portugal, 1 Germany, 1 Hungary, 1 Netherlands)
  • Charité - Universitätsmedizin Berlin · Berlin, Germany
  • Országos Korányi Pulmonológiai Intézet · Budapest, Hungary
  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale Policlinico San Martino · Genova, Italy
  • Ospedale Vito Fazzi Lecce · Lecce, Italy
  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele · Milan, Italy
  • Fondazione IRCCS - Istituto Nazionale dei Tumori · Milan, Italy
  • Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara · Novara, Italy
  • Ospedale Busonera - Istituto Oncologico Veneto (IOV) - Padua · Padova, Italy
  • Azienda Ospedaliero-Universitaria Pisana · Pisa, Italy
  • Azienda Unità Sanitaria Locale della Romagna - Ospedale Infermi di Rimini · Rimini, Italy
  • IRCCS Istituto Nazionale Tumori Regina Elena · Roma, Italy
  • Azienda Ospedaliera San Camillo Forlanini · Rome, Italy
  • Azienda Ospedaliera Universitaria Senese - L'ospedale Santa Maria alle Scotte · Siena, Italy
  • Universitair Medisch Centrum Groningen · Groningen, Netherlands
  • Unidade Local de Saúde de Coimbra · Coimbra, Portugal
  • Hospital CUF Descobertas · Lisbon, Portugal
  • Unidade Local de Saúde de Santa Maria, E. P. E. - Hospital Pulido Valente · Lisbon, Portugal
  • Hospital CUF Porto · Porto, Portugal
  • Unidade Local de Saúde de Gaia/Espinho, E. P. E · Vila Nova de Gaia, Portugal
  • Clínica Mi Tres Torres · Barcelona, Spain
  • Hospital Universitari Dexeus · Barcelona, Spain
  • Hospital Universitari Vall d'Hebrón · Barcelona, Spain
  • Hospital Clinic de Barcelona · Barcelona, Spain
  • Hospital Universitario Reina Sofía · Córdoba, Spain
  • Hospital Universitari de Girona Dr. Josep Trueta · Girona, Spain
  • Hospital Universitario Lucus Augusti · Lugo, Spain
  • Hospital General Universitario Gregorio Marañón · Madrid, Spain
  • Hospital Universitario Ramón y Cajal · Madrid, Spain
  • Hospital Universitario La Paz · Madrid, Spain
  • Hospital Regional Universitario de Málaga - Hospital General · Málaga, Spain
  • …and 1 more on the registry record
Show 31 removed
  • Charité - Universitätsmedizin Berlin · Berlin, Germany
  • Országos Korányi Pulmonológiai Intézet · Budapest, Hungary
  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale Policlinico San Martino · Genova, Italy
  • Ospedale Vito Fazzi Lecce · Lecce, Italy
  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele · Milan, Italy
  • Fondazione IRCCS - Istituto Nazionale dei Tumori · Milan, Italy
  • Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara · Novara, Italy
  • Ospedale Busonera - Istituto Oncologico Veneto (IOV) - Padua · Padova, Italy
  • Azienda Ospedaliero-Universitaria Pisana · Pisa, Italy
  • Azienda Unità Sanitaria Locale della Romagna - Ospedale Infermi di Rimini · Rimini, Italy
  • IRCCS Istituto Nazionale Tumori Regina Elena · Roma, Italy
  • Azienda Ospedaliera San Camillo Forlanini · Rome, Italy
  • Azienda Ospedaliera Universitaria Senese - L'ospedale Santa Maria alle Scotte · Siena, Italy
  • Universitair Medisch Centrum Groningen · Groningen, Netherlands
  • Unidade Local de Saúde de Coimbra · Coimbra, Portugal
  • Hospital CUF Descobertas · Lisbon, Portugal
  • Unidade Local de Saúde de Santa Maria, E. P. E. - Hospital Pulido Valente · Lisbon, Portugal
  • Hospital CUF Porto · Porto, Portugal
  • Unidade Local de Saúde de Gaia/Espinho, E. P. E · Vila Nova de Gaia, Portugal
  • Clínica Mi Tres Torres · Barcelona, Spain
  • Hospital Universitari Dexeus · Barcelona, Spain
  • Hospital Universitari Vall d'Hebrón · Barcelona, Spain
  • Hospital Clinic de Barcelona · Barcelona, Spain
  • Hospital Universitario Reina Sofía · Córdoba, Spain
  • Hospital Universitari de Girona Dr. Josep Trueta · Girona, Spain
  • Hospital Universitario Lucus Augusti · Lugo, Spain
  • Hospital General Universitario Gregorio Marañón · Madrid, Spain
  • Hospital Universitario Ramón y Cajal · Madrid, Spain
  • Hospital Universitario La Paz · Madrid, Spain
  • Hospital Regional Universitario de Málaga - Hospital General · Málaga, Spain
  • …and 1 more on the registry record
across 2 updates, Oct 2, 2026 – Nov 12, 2026
Primary completion
Dec 15, 2027→May 1, 2028
Nov 12, 2026
Show all 2 updates
  1. Nov 12, 2026
    31 sites added, 31 sites removed. Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Istituto Clinico Humanitas is now Recruiting
    Show 31 added (12 Spain, 11 Italy, 5 Portugal, 1 Germany, 1 Hungary, 1 Netherlands)
    • Charité - Universitätsmedizin Berlin · Berlin, Germany
    • Országos Korányi Pulmonológiai Intézet · Budapest, Hungary
    • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale Policlinico San Martino · Genova, Italy
    • Ospedale Vito Fazzi Lecce · Lecce, Italy
    • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele · Milan, Italy
    • Fondazione IRCCS - Istituto Nazionale dei Tumori · Milan, Italy
    • Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara · Novara, Italy
    • Ospedale Busonera - Istituto Oncologico Veneto (IOV) - Padua · Padova, Italy
    • Azienda Ospedaliero-Universitaria Pisana · Pisa, Italy
    • Azienda Unità Sanitaria Locale della Romagna - Ospedale Infermi di Rimini · Rimini, Italy
    • IRCCS Istituto Nazionale Tumori Regina Elena · Roma, Italy
    • Azienda Ospedaliera San Camillo Forlanini · Rome, Italy
    • Azienda Ospedaliera Universitaria Senese - L'ospedale Santa Maria alle Scotte · Siena, Italy
    • Universitair Medisch Centrum Groningen · Groningen, Netherlands
    • Unidade Local de Saúde de Coimbra · Coimbra, Portugal
    • Hospital CUF Descobertas · Lisbon, Portugal
    • Unidade Local de Saúde de Santa Maria, E. P. E. - Hospital Pulido Valente · Lisbon, Portugal
    • Hospital CUF Porto · Porto, Portugal
    • Unidade Local de Saúde de Gaia/Espinho, E. P. E · Vila Nova de Gaia, Portugal
    • Clínica Mi Tres Torres · Barcelona, Spain
    • Hospital Universitari Dexeus · Barcelona, Spain
    • Hospital Universitari Vall d'Hebrón · Barcelona, Spain
    • Hospital Clinic de Barcelona · Barcelona, Spain
    • Hospital Universitario Reina Sofía · Córdoba, Spain
    • Hospital Universitari de Girona Dr. Josep Trueta · Girona, Spain
    • Hospital Universitario Lucus Augusti · Lugo, Spain
    • Hospital General Universitario Gregorio Marañón · Madrid, Spain
    • Hospital Universitario Ramón y Cajal · Madrid, Spain
    • Hospital Universitario La Paz · Madrid, Spain
    • Hospital Regional Universitario de Málaga - Hospital General · Málaga, Spain
    • …and 1 more on the registry record
    Show 31 removed
    • Charité - Universitätsmedizin Berlin · Berlin, Germany
    • Országos Korányi Pulmonológiai Intézet · Budapest, Hungary
    • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale Policlinico San Martino · Genova, Italy
    • Ospedale Vito Fazzi Lecce · Lecce, Italy
    • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele · Milan, Italy
    • Fondazione IRCCS - Istituto Nazionale dei Tumori · Milan, Italy
    • Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara · Novara, Italy
    • Ospedale Busonera - Istituto Oncologico Veneto (IOV) - Padua · Padova, Italy
    • Azienda Ospedaliero-Universitaria Pisana · Pisa, Italy
    • Azienda Unità Sanitaria Locale della Romagna - Ospedale Infermi di Rimini · Rimini, Italy
    • IRCCS Istituto Nazionale Tumori Regina Elena · Roma, Italy
    • Azienda Ospedaliera San Camillo Forlanini · Rome, Italy
    • Azienda Ospedaliera Universitaria Senese - L'ospedale Santa Maria alle Scotte · Siena, Italy
    • Universitair Medisch Centrum Groningen · Groningen, Netherlands
    • Unidade Local de Saúde de Coimbra · Coimbra, Portugal
    • Hospital CUF Descobertas · Lisbon, Portugal
    • Unidade Local de Saúde de Santa Maria, E. P. E. - Hospital Pulido Valente · Lisbon, Portugal
    • Hospital CUF Porto · Porto, Portugal
    • Unidade Local de Saúde de Gaia/Espinho, E. P. E · Vila Nova de Gaia, Portugal
    • Clínica Mi Tres Torres · Barcelona, Spain
    • Hospital Universitari Dexeus · Barcelona, Spain
    • Hospital Universitari Vall d'Hebrón · Barcelona, Spain
    • Hospital Clinic de Barcelona · Barcelona, Spain
    • Hospital Universitario Reina Sofía · Córdoba, Spain
    • Hospital Universitari de Girona Dr. Josep Trueta · Girona, Spain
    • Hospital Universitario Lucus Augusti · Lugo, Spain
    • Hospital General Universitario Gregorio Marañón · Madrid, Spain
    • Hospital Universitario Ramón y Cajal · Madrid, Spain
    • Hospital Universitario La Paz · Madrid, Spain
    • Hospital Regional Universitario de Málaga - Hospital General · Málaga, Spain
    • …and 1 more on the registry record
    Primary completion Dec 15, 2027→May 1, 2028
    + 1 other change: verification date
  2. Oct 2, 2026
    2 sites changed recruiting status (1 now recruiting, 1 now terminated)
    Show 2 sites
    • Cancer Specialists of North Florida Southside · Jacksonville, United StatesActive, not recruiting→Recruiting
    • Universitätsklinikum Aachen · Aachen, GermanyRecruiting→Terminated
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06472245
Lead sponsor
OSE Immunotherapeutics
Collaborators
Exystat, GeneDx
Responsible party
Sponsor
First posted
Jun 25, 2024
Start date
Dec 3, 2024
Primary completion
May 1, 2028 (estimated)
Completion
Dec 15, 2028 (estimated)
Last update
Nov 12, 2026

Study contacts

Caroline Chevalier, MSc, MPH
Contact
caroline.chevalier@ose-immuno.com
+33 630 842 002
Bérangère Vasseur, MD
Contact
berangere.vasseur@ose-immuno.com
+33 676 448 160

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Multi-neo-epitope Vaccine OSE 2101

Start the discussion